Anti-STAT3 (phospho Y705) antibody [EPR23968-52]
- BOND RX™ Validated
- KO Validated
- RabMAb
- Recombinant
- Lab Essentials
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(114 Publications)
Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (ab267373) is a rabbit monoclonal antibody detecting STAT3 in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, IHC-P, ICC/IF, ChIP, Dot Blot. Suitable for Human.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 40 publications
View Alternative Names
APRF, STAT3, Signal transducer and activator of transcription 3, Acute-phase response factor
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (AB267373)
Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling STAT3 (phospho Y705) with ab267373 at 1/500 dilution followed by ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Nuclear staining on human tonsil without alkaline phosphatase treatment (image A) is observed. No signal was detected when tissues were treated with alkaline phosphatase (image B). The section was incubated with ab267373 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (AB267373)
Immunohistochemical analysis of paraffin-embedded human endometrial carcinoma tissue labeling STAT3 (phospho Y705) with ab267373 at 1/500 dilution followed by ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Nuclear staining on human endometrial carcinoma without alkaline phosphatase treatment (image A) is observed. No signal was detected when tissues were treated with alkaline phosphatase (image B). The section was incubated with ab267373 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (AB267373)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 100% Methanol-permeabilized STAT3 KO HeLa cells labelling STAT3 (phospho Y705) with ab267373 at 1/500 dilution, followed by ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) antibody at 1/1000 dilution (Green).
Confocal image showing increased nuclear staining in parental HeLa cells treated with IFN-alpha (50 ng/ml) for 30 min, and no staining in STAT3 knockout HeLa cells treated with IFN-alpha (50 ng/ml) for 30 min.
ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 dilution (Red). The nuclear counterstain was DAPI (Blue).
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (AB267373)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized Jurkat (Human T cell leukemia T lymphocyte) treated with 50 ng/ml IFN-alpha for 30min (Red)/ Untreated control (Green) cells labelling STAT3 (phospho Y705) with ab267373 at 1/500 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue).
A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077 at 1/2000 dilution was used as the secondary antibody.
- ChIP
Supplier Data
ChIP - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (AB267373)
Chromatin was prepared from HepG2 (starved overnight) treated with IL-6 cells and HepG2 (starved overnight) non-treated according to the Abcam Dual-X-ChIP protocol*.
Cells were fixed with 1.5 mM EGS for 30mins and then formaldehyde for 10min.
The ChIP was performed with 25 μg of chromatin, 5 μg of ab267373 (red), or 5 μg of rabbit normal IgG ab172730 (gray) and 25 μl of Protein A/G Dynabeads. The immunoprecipitated DNA was quantified by real time PCR (Sybr green approach).
Primers are purchased from competitor.
*http : //www.abcam.com/resources?keywords=X%20ChIP%20protocol
- IP
Supplier Data
Immunoprecipitation - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (AB267373)
STAT3 (phospho Y705) was immunoprecipitated from 0.35 mg Jurkat (human t cell leukemia cell line from peripheral blood) treated with 50 ng/ml IFN alpha for 30 minutes, whole cell lysate 10 μg with ab267373 at 1/30 dilution (2μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab267373 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : Jurkat treated with 50 ng/ml IFN alpha for 30 minutes, whole cell lysate 10 μg
Lane 2 : ab267373 IP in Jurkat treated with 50 ng/ml IFN alpha for 30 minutes whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab267373 in Jurkat treated with 50 ng/ml IFN alpha for 30 minutes whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 15 seconds.
All lanes:
Immunoprecipitation - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (ab267373)
Predicted band size: 88 kDa
Observed band size: 88 kDa
false
- WB
Lab
Western blot - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (AB267373)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
IFN alpha treatment induces phosphorylation of STAT3 at Tyr705 (PMID : 21957129).
Lysates were made freshly and used in WB immediately to minimize protein degradation.
Exposure time : 3 minutes.
All lanes:
Western blot - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (ab267373) at 1/1000 dilution
Lane 1:
HeLa (human cervix adenocarcinoma epithelial cell) serum starved overnight, whole cell lysate at 20 µg
Lane 2:
HeLa serum starved overnight, then treated with 50 ng/ml IFN alpha for 30 minutes, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 88 kDa
Observed band size: 88 kDa
false
- WB
Lab
Western blot - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (AB267373)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
IL-6 treatment induces phosphorylation of STAT3 at Tyr705 (PMID : 28676732).
Lysates were made freshly and used in WB immediately to minimize protein degradation.
Exposure time : 26 seconds.
All lanes:
Western blot - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (ab267373) at 1/1000 dilution
Lane 1:
HepG2 (human hepatocellular carcinoma epithelial cell) serum starved overnight, whole cell lysate at 20 µg
Lane 2:
HepG2 serum starved overnight, then treated with 100 ng/ml IL-6 for 30 minutes, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 88 kDa
Observed band size: 88 kDa
false
- WB
Lab
Western blot - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (AB267373)
Blocking and diluting buffer and concentration : Intercept® (TBS) Blocking Buffer diluted with an equal volume of 0.1% TBS.
Lanes 1-4 : Merged signal (red and green). Green - ab267373 observed at 88 kDa. Red - loading control ab8245 (Mouse monoclonal [6C5] to GAPDH) observed at 36 kDa.
Lanes 1-2 : ab267373 Anti-STAT3 (phospho Y705) antibody [EPR23968-52] was shown to specifically react with STAT3 in wild-type serum starved and then IFN alpha treated HeLa cells. Loss of signal was observed when serum starved and then IFN alpha treated knockout cell line ab255436 (knockout cell lysate ab263797) was used. Wild-type and STAT3 knockout samples were subjected to SDS-PAGE. ab267373 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at 4°C overnight at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
Lysates loaded onto lanes 3-4 were made freshly and used in WB immediately to minimize protein degradation.
All lanes:
Western blot - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (ab267373) at 1/1000 dilution
Lane 1:
Wild-type HeLa (human cervix adenocarcinoma epithelial cell) serum starved overnight, then treated with 50 ng/ml IFN alpha for 30 minutes, whole cell lysate at 20 µg
Lane 2:
STAT3 knockout HeLa serum starved overnight, then treated with 50 ng/ml IFN alpha for 30 minutes, whole cell lysate at 20 µg
Lane 2:
Western blot - Human STAT3 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-stat3-knockout-hela-cell-line-ab255436'>ab255436</a>)
Lane 3:
Jurkat (human t cell leukemia cell line from peripheral blood) treated with 50 ng/ml IFN alpha for 30 minutes, whole cell lysate at 20 µg
Lane 4:
HepG2 (human hepatocellar carcinoma epithelial cell) serum starved overnight, then treated with 100 ng/ml IL-6 for 30 minutes, whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG H&L (IRDye® 800CW) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) and Goat Anti-Mouse IgG H&L (IRDye® 680RD) (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/10000 dilution
Predicted band size: 88 kDa
Observed band size: 88 kDa
false
- WB
Lab
Western blot - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (AB267373)
Blocking and diluting buffer and concentration : Intercept® (TBS) Blocking Buffer diluted with an equal volume of 0.1% TBS.
Lanes 1-4 : Merged signal (red and green). Green - ab267373 observed at 88 kDa. Red - loading control ab8245 (Mouse monoclonal [6C5] to GAPDH) observed at 36 kDa.
Lanes 1-2 : ab267373 Anti-STAT3 (phospho Y705) antibody [EPR23968-52] was shown to specifically react with STAT3 in wild-type serum starved and then IFN alpha treated HeLa cells. Loss of signal was observed when serum starved and then IFN alpha treated knockout cell line ab255436 (knockout cell lysate ab263797) was used. Wild-type and STAT3 knockout samples were subjected to SDS-PAGE. ab267373 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at 4°C overnight at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
Lysates loaded onto lanes 3-4 were made freshly and used in WB immediately to minimize protein degradation.
All lanes:
Western blot - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (ab267373) at 1/1000 dilution
Lane 1:
Wild-type HeLa (human cervix adenocarcinoma epithelial cell) serum starved overnight, then treated with 50 ng/ml IFN alpha for 30 minutes, whole cell lysate at 20 µg
Lane 2:
STAT3 knockout HeLa serum starved overnight, then treated with 50 ng/ml IFN alpha for 30 minutes, whole cell lysate at 20 µg
Lane 3:
Jurkat (human t cell leukemia cell line from peripheral blood) treated with 50 ng/ml IFN alpha for 30 minutes, whole cell lysate at 20 µg
Lane 4:
HepG2 (human hepatocellar carcinoma epithelial cell) serum starved overnight, then treated with 100 ng/ml IL-6 for 30 minutes, whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG H&L (IRDye® 800CW) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) and Goat Anti-Mouse IgG H&L (IRDye® 680RD) (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/10000 dilution
Predicted band size: 88 kDa
Observed band size: 88 kDa
false
- Dot
Supplier Data
Dot Blot - Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (AB267373)
Dot blot analysis of STAT3 (phospho Y705) using ab267373 at 1/1000 followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution.
Lane 1 : STAT3 phospho Y705 peptide (aa700-710)
Lane 2 : Unmodified STAT3 peptide (aa698-710)
Exposure time : 3 minutes.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Related conjugates and formulations (1)
-
Anti-STAT3 (phospho Y705) antibody [EPR23968-52] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (ab267373) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF), ChIP, Dot Blot in Human samples.
What is the molecular weight of STAT3?
Anti-STAT3 (phospho Y705) [EPR23968-52] (ab267373) specifically detects a band for STAT3 (UniProt: P40763) at a molecular weight of 88kDa.
Trusted by the scientific community
Anti-STAT3 (phospho Y705) [EPR23968-52] (ab267373) was first used in a scientific publication in 2021 and has been cited over 40 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-STAT3 (phospho Y705) antibody [EPR23968-52] (ab267373) has been confirmed by Western blot testing in STAT3 Knockout HeLa cell line, ab255436.
Other related products
We have a range of other formats of antibody clone [EPR23968-52] also available for your convenience: ab267373, Carrier free - ab280202
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
STAT3 is an important player in regulating cell growth and apoptosis. It functions not only as a transcription factor but also as part of a larger protein complex that operates within the cell nucleus to influence gene expression. This multifaceted role enables STAT3 to control the expression of genes related to cell proliferation survival and differentiation impacting various biological processes. These functions highlight its importance in tissue homeostasis and response to extracellular signals.
Pathways
STAT3 is actively involved in the JAK-STAT signaling pathway a principal route for many cytokines and growth factors and the MAPK pathway. STAT3 interacts with proteins such as JAK kinases which phosphorylate Stat3 and initiate the STAT3 signaling cascade. Additionally it closely associates with the protein Raf1 in the MAPK pathway linking external signals to transcriptional responses. These pathways play a significant role in immune response inflammation and growth signaling.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (114)
Recent publications for all applications. Explore the full list and refine your search
Cell division 20:22 PubMed41039618
2025
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasia (New York, N.Y.) 68:101219 PubMed40840329
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1625286 PubMed40832613
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 15:1604377 PubMed40799250
2025
Applications
Unspecified application
Species
Unspecified reactive species
Materials today. Bio 33:102027 PubMed40677394
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 23:409 PubMed40457410
2025
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 15:5826-5845 PubMed40365295
2025
Applications
Unspecified application
Species
Unspecified reactive species
Physiological reports 13:e70360 PubMed40338178
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:278 PubMed40216763
2025
Applications
Unspecified application
Species
Unspecified reactive species
Advanced biology 9:e2400685 PubMed40197728
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com